Cargando…

Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues

Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and miR370 was studied in the renal tissues of patients with systemic lupus nephritis (LN), mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelousi, Anna, Liapis, Georgios, Gazouli, Maria, Kofotolios, Ioannis, Sakellariou, Stratigoula, Boletis, Ioannis, Marinaki, Smaragdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433714/
https://www.ncbi.nlm.nih.gov/pubmed/37477126
http://dx.doi.org/10.3892/mmr.2023.13056
_version_ 1785091711105499136
author Angelousi, Anna
Liapis, Georgios
Gazouli, Maria
Kofotolios, Ioannis
Sakellariou, Stratigoula
Boletis, Ioannis
Marinaki, Smaragdi
author_facet Angelousi, Anna
Liapis, Georgios
Gazouli, Maria
Kofotolios, Ioannis
Sakellariou, Stratigoula
Boletis, Ioannis
Marinaki, Smaragdi
author_sort Angelousi, Anna
collection PubMed
description Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and miR370 was studied in the renal tissues of patients with systemic lupus nephritis (LN), minimal changes disease (MCD) and pauci-immune glumeronephritis (PIN). A total of 51 patients undergoing renal biopsy and 22 nephrectomised controls with no history of parenchymal renal disease were recruited from the Clinic of Nephrology and Renal Transplantation of General Laikon hospital between November 2016 and March 2019. All patients were newly-diagnosed and they were naïve of any treatment. The mRNA and protein expression were analyzed through reverse transcription-quantitative PCR and immunohistochemistry respectively. Written consent was obtained from all participants. GR mRNA expression was significantly reduced in all pathological samples compared with the ‘normal’ renal tissues used as controls (P=0.023 for LN, P=0.05 for MCD and P=0.004 for PIN). Similarly, GR protein expression was lower in all pathological samples (>6 GR positive podocytes/glomerulus in 50% of patients with LN and MCD and 18% with PIN) compared with controls (>6 positive podocytes/glomerulus in all the controls). PIN samples presented significantly lower GR mRNA and protein expression compared with LN and MCD samples. No significant differences were observed in the miR30a expression when comparing pathological with ‘normal’ renal samples. miR24 and miR370 expression demonstrated statistically significant difference in all pathological compared with ‘normal’ tissues. Moreover, GR expression was not significantly associated with either LN disease activity score or the response to the treatment. GR and miR24 expression was significantly reduced whereas miR370 significantly increased in all pathological compared with ‘normal’ renal tissues implying their protentional role in nephritis pathogenesis and treatment. Analysis of larger samples are required for more robust statistical analysis.
format Online
Article
Text
id pubmed-10433714
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-104337142023-08-18 Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues Angelousi, Anna Liapis, Georgios Gazouli, Maria Kofotolios, Ioannis Sakellariou, Stratigoula Boletis, Ioannis Marinaki, Smaragdi Mol Med Rep Articles Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and miR370 was studied in the renal tissues of patients with systemic lupus nephritis (LN), minimal changes disease (MCD) and pauci-immune glumeronephritis (PIN). A total of 51 patients undergoing renal biopsy and 22 nephrectomised controls with no history of parenchymal renal disease were recruited from the Clinic of Nephrology and Renal Transplantation of General Laikon hospital between November 2016 and March 2019. All patients were newly-diagnosed and they were naïve of any treatment. The mRNA and protein expression were analyzed through reverse transcription-quantitative PCR and immunohistochemistry respectively. Written consent was obtained from all participants. GR mRNA expression was significantly reduced in all pathological samples compared with the ‘normal’ renal tissues used as controls (P=0.023 for LN, P=0.05 for MCD and P=0.004 for PIN). Similarly, GR protein expression was lower in all pathological samples (>6 GR positive podocytes/glomerulus in 50% of patients with LN and MCD and 18% with PIN) compared with controls (>6 positive podocytes/glomerulus in all the controls). PIN samples presented significantly lower GR mRNA and protein expression compared with LN and MCD samples. No significant differences were observed in the miR30a expression when comparing pathological with ‘normal’ renal samples. miR24 and miR370 expression demonstrated statistically significant difference in all pathological compared with ‘normal’ tissues. Moreover, GR expression was not significantly associated with either LN disease activity score or the response to the treatment. GR and miR24 expression was significantly reduced whereas miR370 significantly increased in all pathological compared with ‘normal’ renal tissues implying their protentional role in nephritis pathogenesis and treatment. Analysis of larger samples are required for more robust statistical analysis. D.A. Spandidos 2023-07-20 /pmc/articles/PMC10433714/ /pubmed/37477126 http://dx.doi.org/10.3892/mmr.2023.13056 Text en Copyright: © Angelousi et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Angelousi, Anna
Liapis, Georgios
Gazouli, Maria
Kofotolios, Ioannis
Sakellariou, Stratigoula
Boletis, Ioannis
Marinaki, Smaragdi
Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title_full Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title_fullStr Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title_full_unstemmed Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title_short Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues
title_sort analysis of glucocorticoid receptor and micrornas expression in pathological renal tissues
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433714/
https://www.ncbi.nlm.nih.gov/pubmed/37477126
http://dx.doi.org/10.3892/mmr.2023.13056
work_keys_str_mv AT angelousianna analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT liapisgeorgios analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT gazoulimaria analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT kofotoliosioannis analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT sakellarioustratigoula analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT boletisioannis analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues
AT marinakismaragdi analysisofglucocorticoidreceptorandmicrornasexpressioninpathologicalrenaltissues